Sign in to view content

Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2021

Related

Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Updates from the Field
2024
Episode 150: Ophthalmic Genetics with Dr. Mark Pennesi
Jayanth Sridhar, MD
Member Podcasts
2018
OCT Angiographic Metrics for Discriminating Diabetic Retinopathy Stages - Normalized Perfusion Deviation vs Perfusion Density vs FAZ Measurements
Richard B. Rosen, MD, DSc(Hon), FACS, FASRS, FARVO
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more